Sign in
Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis
Conference proceeding   Peer reviewed

Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis

P. J Meunier and J. Y Reginster
Osteoporosis international, Vol.14(3), pp.S66-S76
Optimizing bone formation and resorption with strontium ranelate: an innovative therapeutic approach to osteoporosis
01/01/2003
PMID: 12730769

Abstract

Biological and medical sciences Bones, joints and connective tissue. Antiinflammatory agents Medical sciences Pharmacology. Drug treatments

Metrics

1 Record Views

Details